Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's Disease

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 11, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions
Alzheimer&Amp;#39;s Disease-related DementiaAlzheimer DiseaserTMS Stimulation
Interventions
DEVICE

Brain Stimulation

This intervention is distinct because it combines two non-invasive brain stimulation techniques, intermittent theta burst stimulation (iTBS) and transcranial direct current stimulation (tDCS), in a sequential manner. Unlike studies that evaluate these techniques individually, this study explores their combined and complementary effects, with iTBS priming the brain to enhance the subsequent impact of tDCS. The sequential design leverages different mechanisms of action: iTBS delivers magnetic pulses to targeted brain areas to modulate neural activity, while tDCS applies a low electrical current for sustained modulation. This approach specifically targets neuropsychiatric symptoms (e.g., mood swings, apathy, and agitation) in individuals with Alzheimer's Disease and related dementias (ADRD), a population often underserved by traditional interventions. The study also evaluates the feasibility of at-home tDCS administration, making it unique in combining clinical and caregiver-managed treat

Trial Locations (1)

77030

RECRUITING

Michael E. DeBakey VA Medical Center, Houston

All Listed Sponsors
lead

Baylor College of Medicine

OTHER

NCT06835283 - Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's Disease | Biotech Hunter | Biotech Hunter